Cancer, Caregiver, Pharmacist-Patient Relations, Preference, Patient
Conditions
Keywords
Preference, Patient, Pharmacist-Patient Relations, Cancer of Colon, Cancer, Breast, Lung Cancer, Prostate Cancer, Renal Cancer, caregiver
Brief summary
To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. Their goal is to provide the patient with the means to identify, prevent and limit adverse effects and to know who to refer to in case of a serious adverse effect, perform a pharmaceutical analysis of the prescription, and participate in the improvement and evaluation of overall compliance. OPCs are conditioned by the needs, expectations, and involvement of the patients in their care. In healthcare, patients are increasingly encouraged to play an active role in the knowledge and management of their health, express their concerns and preferences, and participate in medical decisions. Thus, it is essential to elicit their preferences. The discrete-choice experiment (DCE) is the validated and recommended method of the International Society for Pharmacoeconomics and Outcomes Research for such a task.
Detailed description
To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. Their goal is to provide the patient with the means to identify, prevent and limit adverse effects and to know who to refer to in case of a serious adverse effect, perform a pharmaceutical analysis of the prescription, and participate in the improvement and evaluation of overall compliance. OPCs are conditioned by the needs, expectations, and involvement of the patients in their care. In healthcare, patients are increasingly encouraged to play an active role in the knowledge and management of their health, express their concerns and preferences, and participate in medical decisions. Thus, it is essential to elicit their preferences. The discrete-choice experiment (DCE) is the validated and recommended method of the International Society for Pharmacoeconomics and Outcomes Research for such a task.
Interventions
None listed
Sponsors
Centre Hospitalier Universitaire de Besancon
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
of patients: Main inclusion Criteria: * Patients with lung, prostate breast, prostate or renal cancer; * Patients with oral cancer drugs; * Patients accepted to take par in pharmaceutical consultation in hospital.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Preferences of patients | 12 months | utility associated with each attribute |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Preferences of cargivers and healthcare profesionnals | 12 months | utility associated with each attribute |
Countries
France
Outcome results
None listed